COMMUNIQUÉS West-GlobeNewswire

Alavida Health Selected for C100’s 48 Hours in the Valley

15/05/2018 - 07:20

VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Alavida Health , a science and technology-based treatment program for alcohol addiction, announced today that they have been selected to participate in the [...]

Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Saudi Arabia by Hikma Pharmaceuticals LLC

15/05/2018 - 07:16

Basel, Switzerland, May 15, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its partner Hikma Pharmaceuticals LLC has launched Basilea's hospital antibiotic Zevtera ® (ceftobiprole) in Saudi Arabia. [...]

Novartis ARROW trial to assess mechanistic superiority of direct IL-17A inhibition (Cosentyx®) over IL-23 inhibition (Tremfya®*)

15/05/2018 - 07:16

ARROW study to assess the mechanistic superiority of direct IL-17A inhibition (Cosentyx) over IL-23 inhibition (Tremfya ® *) in clearing of Stelara ® *-resistant psoriatic plaques[1] This is the 100 th trial with [...]

Fagron shareholders approve all proposed resolutions

15/05/2018 - 07:00

Nazareth (Belgium) / Rotterdam (The Netherlands), 15 May 2018 Regulated information Fagron announces today that the annual general meeting of shareholders and the extraordinary shareholders meeting, both held on 14 May [...]

Probiodrug AG reports First Quarter 2018 Business Update

15/05/2018 - 07:00

Probiodrug AG reports First Quarter 2018 Business Update HALLE (SAALE), Germany, 15 May 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company developing novel therapeutic solutions [...]

Novartis completes tender offer for all outstanding shares of AveXis, Inc.

15/05/2018 - 06:46

Basel, May 15, 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced the successful completion of the previously announced tender offer by its indirect wholly-owned subsidiary, Novartis AM Merger Corporation (" [...]

Loop Industries Reports Fourth Quarter and Fiscal 2018 Consolidated Results

15/05/2018 - 04:57

Company used $2.2 million for the quarter and $6.4 million for the fiscal year of cash in operating activities to significantly advance its technology and fund its growth strategy Raised $8.6 million through a private [...]

Sirona Biochem Receives TSX Venture Exchange Approval on Warrant Extension

15/05/2018 - 04:19

VANCOUVER, British Columbia, May 14, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM ) (FRANKFURT: ZSB ), announces an extension to the term of 2,073,750 common share purchase warrants (the “Warrants”) [...]

BIONOVELUS' FIRST QUARTER REPORTS

15/05/2018 - 02:45

FOR IMMEDIATE RELEASE — Phoenix, May 14, 2018 (GLOBE NEWSWIRE) -- / BioNovelus (OTC Pink: ONOV) has published today its first quarter of 2018 financial statements and report. This information is attached to this Press [...]

MediSix Therapeutics Launches with USD$20M Series A Financing

15/05/2018 - 01:00

Company will develop novel CAR-T immune engineering platform targeting T-cell malignancies SINGAPORE, May 14, 2018 (GLOBE NEWSWIRE) -- MediSix Therapeutics Pte. Ltd., a development-stage cell therapy company creating [...]

Arcturus Therapeutics Files Form 20-F

14/05/2018 - 23:33

SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today announced the filing of the Company’s Annual Report on Form 20-F for the fiscal year ended [...]

Mustang Bio Reports First Quarter 2018 Financial Results

14/05/2018 - 23:30

NEW YORK, May 14, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

ADMA Biologics Reports First Quarter 2018 Financial Results

14/05/2018 - 23:05

Key Manufacturing Milestones Achieved During First Quarter RAMSEY, N.J. and BOCA RATON, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) (“ADMA” or the “Company”), today announced its [...]

EDAP TMS SA : EDAP Reports 2018 First Quarter Results

14/05/2018 - 23:00

2018 Q1 total revenue records a 6% increase year-over-year Focal One Final Additional Information submitted to FDA early May EDAP to attend American Urological Association congress in San Francisco, May 18-21, 2018 LYON [...]

Invuity Announces Results of New PhotonBlade® Studies at 2018 Heart Rhythm Society Conference

14/05/2018 - 22:50

Researchers identify critical factors to minimize damage when using electrocautery near insulated pacing leads and demonstrate a reduced risk of damaging lead insulation with the use of PhotonBlade SAN FRANCISCO, May 14 [...]

Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of XEN1101 and XEN901 Presentations at 14th Eilat Conference

14/05/2018 - 22:46

BURNABY, British Columbia, May 14, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical-stage biopharmaceutical company, today announced that it will provide a corporate update and overview of [...]

IMV Inc. (Formerly Immunovaccine Inc.) Announces Q1 2018 Financial Results

14/05/2018 - 22:35

HALIFAX, Nova Scotia, May 14, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX: IMV ) (OTCQX:IMMVD), a clinical stage immuno-oncology corporation, today released its financial and operational results for the first quarter ended [...]

ERYTECH Reports First Quarter 2018 Financial Results and Provides Business Update

14/05/2018 - 22:30

Conference call and webcast scheduled for Tuesday, May 15th at 2:30 pm CET/8:30 am EDT Finalized Phase 3 trial design for eryaspase in second line pancreatic cancer; on track for expected start of patient enrollment in [...]

Molecular Templates, Inc. Reports First Quarter 2018 Financial Results

14/05/2018 - 22:30

MT-3724 Phase Ib Ongoing; Combination Studies Expected to Start in 2H18 AUSTIN, Texas, May 14, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM ) (“Molecular”), a clinical-stage oncology company focused [...]